secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001213900-24-077790
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to Oct 11, 2024 via trust deposit
--------------------------------------------------------------------------------

- Deposited $15,063.74 into trust to extend deadline one month from Sept 11 to Oct 11, 2024.
- Funding from Scilex Holding (SCLX) convertible promissory note up to $180,000, zero interest.
- Note convertible into DECA Class A shares at $10.00 per share upon business combination close.
- Remaining $149,899.52 of note principal available to fund further monthly extensions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024077790/0001213900-24-077790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024077790/ea0214299-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer